Category: United States
-
BREAKING: Federal Circuit affirms Masimo’s initial ITC win over Apple — but Masimo not too likely to benefit based on what happened yesterday
For Masimo, this is a useless win if the ITC, as is now rather likely after a preliminary ruling, clears Apple’s workaround.
-
ZTE, Samsung now awaiting four court rulings after recent trials: considerable risk of knockout punches; Samsung already trying to avoid costs in U.S.
Four ZTE-Samsung cases are under advisement in four different courts in three different countries. Two of them could get Samsung into trouble and the other two may not go well either.
-
Colombia pushes for compulsory licensing of U.S. pharma company’s patents
Colombia’s Health Minister has revived a previous administration’s investigation into four of U.S. pharma company Gilead’s patents at the core of Hepatitis-C treatment, issuing a public interest declaration to make the licensing of such patents compulsory.
-
First U.S. patent long-arm assertions in German court withdrawn with prejudice as Onesta settles with Qualcomm; separately, NVIDIA settled
The realistic best-case scenario for BMW materialized with respect to costs. But the overall course of events will not completely discourage others from pulling an Onesta.
-
Apple settles wide-angle camera patent infringement dispute in District of Delaware after successfully invoking “single-means” doctrine
Apple has settled two parallel actions brought by Canada’s Immervision over the alleged infringement of the latter’s wide-angle camera-related patents, bringing the companies’ five-year dispute to an end.
-
Novo Nordisk settles U.S. semaglutide patent infringement dispute, but denied Indian interim injunction again
While Novo Nordisk has struck an agreement with U.S. telehealth platform Hims & Hers to sell Ozempic and Wegovy, the Delhi High Court has once again denied its request for an interim injunction against Dr. Reddy’s Laboratories to block its sales of semaglutide products after its patent expires in 10 days.
-
Adeia continues licensing streak: ends AMD dispute with semiconductor patent deal
U.S. patent licensing firm Adeia has ended its U.S. patent litigation against Advanced Micro Devices with a multi-year license agreement granting the latter access to its semiconductor patent portfolio.
-
Acer divests U.S. communications patent to NPE amid Nokia, Ericsson litigation
Acer has recently reassigned one of its electronics-related patents to a U.S. non-practising entity, according to the United States Patent and Trademark Office’s assignment records, as the company continues to battle Nokia patent infringement claims and bring its own against Ericsson.
-
Dolby attacks six InterDigital patents in U.S. court to protect its customers Amazon, Disney, TCL, Hisense
Dolby has recently filed a petition for inter partes review against an InterDigital patent, but is now going against five more patents.
-
Moderna, Genevant, Arbutus settle global mRNA patent infringement dispute
Moderna could have to pay up to $2.25 billion as part of the settlement agreement, but remains confident it will close 2026 with up to $5 billion in cash and cash equivalents as a result of the deal.